Lv11
60 积分 2024-03-18 加入
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
3小时前
待确认
Pooled Rate of Pseudoprogression, Patterns of Response, and Tumor Burden Analysis in Patients Undergoing Immunotherapy Oncologic Trials for Different Malignancies
4小时前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
1个月前
已完结
皖公网安备34019202002308
